95
Participants
Start Date
September 30, 2024
Primary Completion Date
January 24, 2028
Study Completion Date
January 24, 2028
REGN7999
Administered subcutaneous (SC)
Placebo
Administered SC
RECRUITING
Weill Cornell Medicine, New York
RECRUITING
Chulalongkorn University, Bangkok
RECRUITING
Phramongkutklao Hospital, Bangkok
RECRUITING
Srinagarind Hospital, Khon Kaen
RECRUITING
Day Hospital Thalassemia and Haemoglobinopathies (DHTE); A.O.U S.Anna, Ferrara
RECRUITING
Chiang Mai University, Chiang Mai
RECRUITING
Hospital Tunku Ampuan Besar Tuanku Aishah Rohani (HPKK UKM), Kuala Lumpur
RECRUITING
Hospital Ampang, Ampang
RECRUITING
Hospital Queen Elizabeth, Kota Kinabalu
RECRUITING
Songklanagarind Hospital, Prince of Songkla University, Hat Yai
RECRUITING
Sarawak General Hospital, Kuching
RECRUITING
All India Institute of Medical Sciences, New Delhi, New Delhi
RECRUITING
Indraprastha Apollo Hospitals, Delhi
RECRUITING
JK Lon Hospital, Jaipur
RECRUITING
Hemato-Oncology Clinic Ahmedabad PVT. LTD., Ahmedabad
RECRUITING
Nirmal Hospital Pvt. Ltd - Surat, Surat
RECRUITING
K J Somaiya Super Specialty Hospital & Research Centre, Mumbai
RECRUITING
Amrita Institute of Medical Sciences and Research Centre (AIMS), Kochi
RECRUITING
K Eristavi National Center of Experimental and Clinical Surgery, Tbilisi
RECRUITING
Medinvest Institute of Hematology and Transfusiology Limited, Tbilisi
RECRUITING
University College London Hospitals NHS Trust, London
RECRUITING
Imperial College Healthcare NHS Trust, London
Regeneron Pharmaceuticals
INDUSTRY